- 全部删除
- 您的购物车当前为空
Lusutrombopag (Mulpleta) 是一种口服生物可利用的小分子血小板生成素 (TPO) 受体激动剂,用于选择性侵入性手术前患有血小板减少症的慢性肝病的患者。
Lusutrombopag (Mulpleta) 是一种口服生物可利用的小分子血小板生成素 (TPO) 受体激动剂,用于选择性侵入性手术前患有血小板减少症的慢性肝病的患者。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 627 | In stock | |
2 mg | ¥ 919 | In stock | |
5 mg | ¥ 1,530 | In stock | |
10 mg | ¥ 2,430 | In stock | |
25 mg | ¥ 4,150 | In stock | |
50 mg | ¥ 5,920 | In stock | |
100 mg | ¥ 8,180 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 1,960 | In stock |
Lusutrombopag 相关产品
产品描述 | Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. |
体外活性 | Lusutrombopag is an agonist of the thrombopoietin receptor that activates platelet production. Lusutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels. |
别名 | 鲁索曲波帕, 芦曲泊帕, S-888711, Mulpleta |
分子量 | 591.55 |
分子式 | C29H32Cl2N2O5S |
CAS No. | 1110766-97-6 |
Smiles | CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(\C=C(/C)C(O)=O)c(Cl)c3)n2)c1OC |
密度 | 1.299 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 30 mg/mL (50.71 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容